Dynamic Advisor Solutions LLC Increases Stake in ARK Genomic Revolution ETF

On October 13, 2024, it was reported that Dynamic Advisor Solutions LLC has expanded its investment in the ARK Genomic Revolution ETF (BATS:ARKG) by 7.8% during the third quarter of the year. This increase is highlighted in their recent filing with the Securities and Exchange Commission (SEC).

Following this acquisition, Dynamic Advisor Solutions LLC now holds a total of 13,590 shares of the ARK Genomic Revolution ETF, having purchased an additional 989 shares over the last quarter. As of the latest reporting period, the value of these holdings is approximately $348,000.

In addition to Dynamic Advisor Solutions LLC, several other institutional investors have also made changes to their holdings in the ARK Genomic Revolution ETF. Notably, First Horizon Advisors Inc. increased its stake by 9.4% during the second quarter, bringing its total to 4,650 shares valued at around $109,000 after acquiring an additional 398 shares.

Meanwhile, Prospect Financial Services LLC reported a 3.7% growth in its stake, currently holding 14,093 shares, valued at $331,000 after a purchase of 500 shares. Bridges Investment Management Inc. also increased its holdings by 3.8%, ending the last quarter with 14,121 shares worth $332,000 after buying 517 additional shares.

Brown Miller Wealth Management LLC raised its investment in ARK Genomic Revolution ETF by 4.4% in the first quarter, with a total of 16,823 shares valued at $483,000 after purchasing 714 additional shares. Finally, SkyOak Wealth LLC made a notable increase of 14.2%, owning 8,029 shares currently valued at approximately $231,000 after buying an additional 1,000 shares during the last quarter.

Recent Performance of ARK Genomic Revolution ETF

As of the latest trading session, ARK Genomic Revolution ETF opened at $24.79. The stock's 50-day moving average stands at $25.39, while its 200-day moving average is noted at $25.36, indicating a stable performance over recent months.

Understanding ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF is an actively managed exchange-traded fund that primarily invests in companies that are engaged in the genomics sector. Launched on October 31, 2014, the ETF aims to capitalize on advancements and innovations within the genomics field, managed by ARK Investment Management.

Further Reading and Information

For those interested in learning more about investments, other listed articles include topics such as stocks with high potential, insights into technology stocks, mid-cap stocks with insider buying, and market fluctuations that investors should be aware of.

For real-time updates about the ARK Genomic Revolution ETF and its holdings by other hedge funds, it is advisable to visit platforms that track 13F filings and insider trades.

Dynamic, Advisor, Solutions